| 000 | 00000nas 2200000za 4500 |
| 001 | 9.505060 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107133448 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406d20022014oncqr p o f0 a0eng|d |
|---|
| 022 | |a1499-9455|y1499-9447 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-4/1E-PDF |
|---|
| 130 | 0 |aCanadian adverse reaction newsletter (Online) |
|---|
| 245 | 10|aCanadian adverse reaction newsletter |h[electronic resource]. |
|---|
| 260 | |aOttawa : |bHealth Canada, Marketed Health Products Directorate, |c2002-2014. |
|---|
| 310 | |aQuarterly |
|---|
| 362 | 1 |aBegan with vol. 12, no. 2 (Apr. 2002); ceased with v. 24, no. 4 (Oct. 2014). |
|---|
| 500 | |aIssued also in French under title: Bulletin canadien des effets indésirables. |
|---|
| 520 | 3 |aA reputable source of adverse reaction information. Alerts health professionals to potential signals detected through the review of case reports submitted to Health Canada. It is a useful mechanism to disseminate information on suspected adverse reactions to health products occurring in humans before comprehensive risk-benefit evaluations and regulatory decisions are undertaken. |
|---|
| 690 | 07|aAdverse effects|2gcpds |
|---|
| 690 | 07|aHealth care products|2gcpds |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |bMarketed Health Products Directorate. |
|---|
| 775 | 08|tBulletin canadien des effets indésirables |w(CaOODSP)9.501459 |
|---|
| 776 | 0#|tCanadian adverse reaction newsletter / |w(CaOODSP)9.514270 |
|---|
| 780 | 00|tCanadian adverse drug reaction newsletter |w(CaOODSP)9.504389 |
|---|
| 785 | 00|tHealth product infoWatch |w(CaOODSP)9.507963 |
|---|